Minerva neurosciences, inc. (NERV)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13
Expenses
Research and development

58,124

34,888

30,255

20,439

18,533

42,908

708

General and administrative

17,740

16,841

10,914

9,750

7,576

11,961

2,466

Total expenses

75,865

51,729

41,170

30,190

26,109

54,870

3,174

Loss from operations

-75,865

-51,729

-41,170

-30,190

-26,109

-54,870

-3,174

Foreign exchange losses

-28

-4

-56

-23

-15

18

-28

Investment income

1,456

1,673

941

198

96

-

-

Interest expense

-

-110

-614

-1,029

-1,053

-2,049

-

Loss before income taxes

-74,437

-50,171

-40,899

-31,045

-27,081

-

-

Benefit for income taxes

-2,254

0

-9,376

0

0

-

-

Net loss

-72,183

-50,171

-31,523

-31,045

-27,081

-56,901

-

Interest (expense) income

-

-

-

-

-

-

-58

Net loss

-

-

-

-

-

-

-3,262

Net loss per share, basic and diluted

-1.85

-1.29

-0.83

-0.99

-1.16

-4.47

-0.78

Weighted average shares outstanding, basic and diluted

39,014

38,792

37,937

31,514

23,412

12,724

4,186